CD133, CD44, CD44v6, and Lgr5 were identified as CSC surface markers for CRCs, and CD44v6+ lineage-CSCs are associated with CRC malignancies and metastatic transformations. This evidence concerns the gene LGR5 and colorectal carcinoma.